scholarly journals Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica

2007 ◽  
Vol 45 (5) ◽  
pp. 1447-1454 ◽  
Author(s):  
M. Safaeian ◽  
R. Herrero ◽  
A. Hildesheim ◽  
W. Quint ◽  
E. Freer ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Costa Rica ◽  
Young Women ◽  
Hybrid Capture ◽  
Hybrid Capture 2

Anal Human Papillomavirus Testing with Digeneʼs Hybrid Capture 2 Using Two Different Sampling Methods

2008 ◽  
Vol 51 (1) ◽  
pp. 62-66 ◽  
Author(s):  
Florian Roka ◽  
Julia Roka ◽  
Andreas Trost ◽  
Horst Schalk ◽  
Christian Zagler ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Sampling Methods ◽  
Hybrid Capture ◽  
Human Papillomavirus Testing ◽  
Hybrid Capture 2

scholarly journals Low prevalence of high risk human papillomavirus in normal oral mucosa by hybrid capture 2

2008 ◽  
Vol 39 (1) ◽  
Author(s):  
Maria del Refugio González-Losa ◽  
Luis Manzano-Cabrera ◽  
Florencio Rueda-Gordillo ◽  
Sandra E. Hernández-Solís ◽  
Marylin Puerto-Solís
Keyword(s):  
Human Papillomavirus ◽  
High Risk ◽  
Oral Mucosa ◽  
Hybrid Capture ◽  
Normal Oral Mucosa ◽  
Hybrid Capture 2 ◽  
Low Prevalence

scholarly journals Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women

2017 ◽  
Vol 148 (2) ◽  
pp. 148-153 ◽  
Author(s):  
Zizipho Z. A. Mbulawa ◽  
Timothy Wilkin ◽  
Bridgette J. Goeieman ◽  
Eefje Jong ◽  
Pamela Michelow ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
South African ◽  
Hybrid Capture ◽  
Hybrid Capture 2 ◽  
And Performance ◽  
Hpv Assays

scholarly journals Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders

2017 ◽  
Vol 55 (10) ◽  
pp. 2913-2923 ◽  
Author(s):  
J. U. H. Lam ◽  
M. Rebolj ◽  
D. M. Ejegod ◽  
H. Pedersen ◽  
C. Rygaard ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Reference Population ◽  
Hybrid Capture ◽  
Hpv Prevalence ◽  
Screening Participation ◽  
Hybrid Capture 2 ◽  
Management Of Hpv ◽  
Hpv Assays ◽  
Level Of Agreement

ABSTRACT The Copenhagen Self-Sampling Initiative (CSi) has shown how human papillomavirus (HPV)-based self-sampling can be used to increase screening participation among 23,632 nonattenders in the Capital Region of Denmark. In this study, we describe HPV prevalence and genotype frequency in 4,824 self-samples as determined by three HPV assays (the CLART, Onclarity, and Hybrid Capture 2 [HC2] assays) and compare the results with those for physician-taken follow-up samples. The HPV self-sample findings were also compared to the findings for a reference population of 3,347 routinely screened women from the Horizon study, which had been undertaken in the same screening laboratory. Nonattenders had an HPV prevalence of 11.3% as determined by the CLART assay, which was lower than that for women from the Horizon study (18.5%). One-third of the CSi women who tested HPV positive by self-sampling tested HPV negative on the physician-taken follow-up sample. The CLART and Onclarity assays agreed on 64% (95% confidence interval [CI], 60 to 68%) of the HPV-positive self-taken samples. When the HC2 assay results were added into a three-way comparison, the level of agreement decreased to 27% (95% CI, 24 to 29%). Our findings suggest that further validation of HPV assays on self-taken samples is needed for optimal HPV detection and correct clinical management of HPV-positive women.

Novaprep® Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2

2010 ◽  
Vol 49 (4) ◽  
pp. 286-289 ◽  
Author(s):  
Jean-Luc Prétet ◽  
Chrystelle Vidal ◽  
Karine Le Bail Carval ◽  
Rajeev Ramanah ◽  
Xavier Carcopino ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
High Risk ◽  
Hybrid Capture ◽  
Human Papillomavirus Testing ◽  
Hybrid Capture 2 ◽  
Liquid Based Cytology
Sign in / Sign up

Export Citation Format

Share Document